Table: Wakamoto Pharm - 9-MTH parent results

Wakamoto Pharmaceutical

05/02/2025 06:32

Feb 5 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             5.81                5.59                      
                 (+3.9 pct)          (-10.9 pct)                  
  Operating     loss 341 mln        loss 259 mln                  
  Recurring     loss 297 mln        loss 225 mln                  
  Net            loss 19 mln        loss 205 mln                  
  EPS           loss 0.55 yen       loss 5.92 yen                 
  Ann Div                             3.00 yen                    
  -Q2 div            NIL                 NIL                      
  -Q4 div                             3.00 yen                    
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T